Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 422

1.

A single institution experience of Eppikajutsuto for the treatment of lymphatic malformations in children.

Goto Y, Yamashita M, Kakuta K, Mahchino K, Ogata S, Mimori K, Shimizu H, Tanaka H.

J Pediatr Surg. 2019 Oct 5. pii: S0022-3468(19)30565-2. doi: 10.1016/j.jpedsurg.2019.08.025. [Epub ahead of print]

PMID:
31669127
2.

Distinct methylation levels of mature microRNAs in gastrointestinal cancers.

Konno M, Koseki J, Asai A, Yamagata A, Shimamura T, Motooka D, Okuzaki D, Kawamoto K, Mizushima T, Eguchi H, Takiguchi S, Satoh T, Mimori K, Ochiya T, Doki Y, Ofusa K, Mori M, Ishii H.

Nat Commun. 2019 Aug 29;10(1):3888. doi: 10.1038/s41467-019-11826-1.

3.

miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.

Mukohyama J, Isobe T, Hu Q, Hayashi T, Watanabe T, Maeda M, Yanagi H, Qian X, Yamashita K, Minami H, Mimori K, Sahoo D, Kakeji Y, Suzuki A, Dalerba P, Shimono Y.

Cancer Res. 2019 Oct 15;79(20):5151-5158. doi: 10.1158/0008-5472.CAN-18-3544. Epub 2019 Aug 15.

PMID:
31416845
4.

Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.

Kouyama Y, Masuda T, Fujii A, Ogawa Y, Sato K, Tobo T, Wakiyama H, Yoshikawa Y, Noda M, Tsuruda Y, Kuroda Y, Eguchi H, Ishida F, Kudo SE, Mimori K.

Cancer Sci. 2019 Oct;110(10):3132-3144. doi: 10.1111/cas.14163. Epub 2019 Aug 29.

5.

Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer.

Sato K, Masuda T, Hu Q, Tobo T, Gillaspie S, Niida A, Thornton M, Kuroda Y, Eguchi H, Nakagawa T, Asano K, Mimori K.

EBioMedicine. 2019 Jun;44:387-402. doi: 10.1016/j.ebiom.2019.05.058. Epub 2019 Jun 4.

6.

Potentials of C-C motif chemokine 2-C-C chemokine receptor type 2 blockers including propagermanium as anticancer agents.

Yumimoto K, Sugiyama S, Mimori K, Nakayama KI.

Cancer Sci. 2019 Jul;110(7):2090-2099. doi: 10.1111/cas.14075. Epub 2019 Jun 10. Review.

7.

Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis.

Muto Y, Moroishi T, Ichihara K, Nishiyama M, Shimizu H, Eguchi H, Moriya K, Koike K, Mimori K, Mori M, Katayama Y, Nakayama KI.

J Exp Med. 2019 Apr 1;216(4):950-965. doi: 10.1084/jem.20180900. Epub 2019 Mar 15.

8.

A clinical trial of somatic and germline analyses for healthy longevity in a postoperative cancer patient.

Hayashi N, Kuroda Y, Saito T, Tsuruda Y, Niida A, Otsu H, Eguchi H, Masuda T, Suzuki Y, Natsugoe S, Mimori K.

Surg Today. 2019 Sep;49(9):738-747. doi: 10.1007/s00595-019-01789-7. Epub 2019 Mar 6.

PMID:
30843125
9.

Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens.

Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F, Takahashi K, Takamochi K, Suzuki K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, Nagase T, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku M, Miyazono K, Miyagawa K, Aburatani H, Mano H.

Cancer Sci. 2019 Apr;110(4):1464-1479. doi: 10.1111/cas.13968. Epub 2019 Mar 5.

10.

Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer.

Kurashige J, Yokobori T, Mima K, Sawada G, Takahashi Y, Ueo H, Takano Y, Matsumura T, Uchi R, Eguchi H, Sudo T, Sugimachi K, Mori M, Baba H, Mimori K.

Oncol Lett. 2019 Feb;17(2):2393-2399. doi: 10.3892/ol.2018.9819. Epub 2018 Dec 11.

11.

Age-related remodelling of oesophageal epithelia by mutated cancer drivers.

Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, Sato Y, Sawada G, Mimori K, Minamiguchi S, Haga H, Seno H, Miyano S, Makishima H, Muto M, Ogawa S.

Nature. 2019 Jan;565(7739):312-317. doi: 10.1038/s41586-018-0811-x. Epub 2019 Jan 2.

PMID:
30602793
12.

CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis.

Shimizu D, Masuda T, Sato K, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Kodera Y, Mimori K.

Anticancer Res. 2019 Jan;39(1):99-106. doi: 10.21873/anticanres.13084.

PMID:
30591445
13.

Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors.

Sato K, Niida A, Masuda T, Shimizu D, Tobo T, Kuroda Y, Eguchi H, Nakagawa T, Suzuki Y, Mimori K.

Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):21-27. doi: 10.21873/cgp.20109.

14.

ASO Author Reflections: ARL4C and Peritoneal Dissemination in Gastric Cancer.

Hu Q, Mimori K.

Ann Surg Oncol. 2018 Dec 17. doi: 10.1245/s10434-018-7056-7. [Epub ahead of print] No abstract available.

PMID:
30556117
15.

Cytolytic Activity (CYT) Score Is a Prognostic Biomarker Reflecting Host Immune Status in Hepatocellular Carcinoma (HCC).

Wakiyama H, Masuda T, Motomura Y, Hu Q, Tobo T, Eguchi H, Sakamoto K, Hirakawa M, Honda H, Mimori K.

Anticancer Res. 2018 Dec;38(12):6631-6638. doi: 10.21873/anticanres.13030.

PMID:
30504371
16.

Cancer evolution and heterogeneity.

Mimori K, Saito T, Niida A, Miyano S.

Ann Gastroenterol Surg. 2018 Jul 4;2(5):332-338. doi: 10.1002/ags3.12182. eCollection 2018 Sep. Review.

17.

Prognostic Impact of Immune-Related Gene Expression in Preoperative Peripheral Blood from Gastric Cancer Patients.

Ito S, Fukagawa T, Noda M, Hu Q, Nambara S, Shimizu D, Kuroda Y, Eguchi H, Masuda T, Sato T, Katai H, Sasako M, Mimori K.

Ann Surg Oncol. 2018 Nov;25(12):3755-3763. doi: 10.1245/s10434-018-6739-4. Epub 2018 Sep 10.

PMID:
30203407
18.

Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy.

Sugimachi K, Sakimura S, Kuramitsu S, Hirata H, Niida A, Iguchi T, Eguchi H, Masuda T, Morita M, Toh Y, Maehara Y, Suzuki Y, Mimori K.

Br J Cancer. 2018 Aug;119(4):419-423. doi: 10.1038/s41416-018-0208-5. Epub 2018 Aug 3.

19.

Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.

Masuda T, Shinden Y, Noda M, Ueo H, Hu Q, Yoshikawa Y, Tsuruda Y, Kuroda Y, Ito S, Eguchi H, Ohno S, Mimori K.

Anticancer Res. 2018 Aug;38(8):4515-4523. doi: 10.21873/anticanres.12755.

PMID:
30061217
20.

A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.

Saito T, Niida A, Uchi R, Hirata H, Komatsu H, Sakimura S, Hayashi S, Nambara S, Kuroda Y, Ito S, Eguchi H, Masuda T, Sugimachi K, Tobo T, Nishida H, Daa T, Chiba K, Shiraishi Y, Yoshizato T, Kodama M, Okimoto T, Mizukami K, Ogawa R, Okamoto K, Shuto M, Fukuda K, Matsui Y, Shimamura T, Hasegawa T, Doki Y, Nagayama S, Yamada K, Kato M, Shibata T, Mori M, Aburatani H, Murakami K, Suzuki Y, Ogawa S, Miyano S, Mimori K.

Nat Commun. 2018 Jul 23;9(1):2884. doi: 10.1038/s41467-018-05226-0.

21.

Overexpression of FGFR1 Promotes Peritoneal Dissemination Via Epithelial-to-Mesenchymal Transition in Gastric Cancer.

Shimizu D, Saito T, Ito S, Masuda T, Kurashige J, Kuroda Y, Eguchi H, Kodera Y, Mimori K.

Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):313-320. doi: 10.21873/cgp.20089.

22.

Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma.

Iguchi T, Ueda M, Masuda T, Nambara S, Kidogami S, Komatsu H, Sato K, Tobo T, Ogawa Y, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K.

Oncology. 2018;95(3):179-187. doi: 10.1159/000488860. Epub 2018 Jun 15.

PMID:
29909415
23.

The Hippo Signaling Pathway: A Candidate New Drug Target for Malignant Tumors.

Nishio M, Goto H, Suzuki M, Fujimoto A, Mimori K, Suzuki A.

In: Nakao K, Minato N, Uemoto S, editors. Innovative Medicine: Basic Research and Development [Internet]. Tokyo: Springer; 2015.

24.

PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.

Kiyozumi Y, Iwatsuki M, Kurashige J, Ogata Y, Yamashita K, Koga Y, Toihata T, Hiyoshi Y, Ishimoto T, Baba Y, Miyamoto Y, Yoshida N, Yanagihara K, Mimori K, Baba H.

Int J Cancer. 2018 Sep 1;143(5):1202-1211. doi: 10.1002/ijc.31410. Epub 2018 Apr 20.

25.

GWAS identifies two novel colorectal cancer loci at 16q24.1 and 20q13.12.

Tanikawa C, Kamatani Y, Takahashi A, Momozawa Y, Leveque K, Nagayama S, Mimori K, Mori M, Ishii H, Inazawa J, Yasuda J, Tsuboi A, Shimizu A, Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Wakai K, Koyama T, Takezaki T, Yuji K, Murakami Y, Nakamura Y, Kubo M, Matsuda K.

Carcinogenesis. 2018 May 3;39(5):652-660. doi: 10.1093/carcin/bgy026.

PMID:
29471430
26.

Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients.

Shinden Y, Sugimachi K, Tanaka F, Fujiyoshi K, Kijima Y, Natsugoe S, Mimori K.

Mol Clin Oncol. 2018 Jan;8(1):93-98. doi: 10.3892/mco.2017.1502. Epub 2017 Nov 15.

27.

Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling.

Niida A, Nagayama S, Miyano S, Mimori K.

Cancer Sci. 2018 Apr;109(4):884-892. doi: 10.1111/cas.13510. Epub 2018 Feb 28. Review.

28.

Preventive and promotive effects of habitual hot spa-bathing on the elderly in Japan.

Maeda T, Mimori K, Suzuki S, Horiuchi T, Makino N.

Sci Rep. 2018 Jan 9;8(1):133. doi: 10.1038/s41598-017-18488-3.

29.

Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer.

Nambara S, Masuda T, Nishio M, Kuramitsu S, Tobo T, Ogawa Y, Hu Q, Iguchi T, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Saeki H, Oki E, Maehara Y, Suzuki A, Mimori K.

Oncotarget. 2017 Nov 21;8(64):107666-107677. doi: 10.18632/oncotarget.22587. eCollection 2017 Dec 8.

30.

Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.

Sakai E, Nakayama M, Oshima H, Kouyama Y, Niida A, Fujii S, Ochiai A, Nakayama KI, Mimori K, Suzuki Y, Hong CP, Ock CY, Kim SJ, Oshima M.

Cancer Res. 2018 Mar 1;78(5):1334-1346. doi: 10.1158/0008-5472.CAN-17-3303. Epub 2017 Dec 27.

31.

Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.

Hu Q, Masuda T, Sato K, Tobo T, Nambara S, Kidogami S, Hayashi N, Kuroda Y, Ito S, Eguchi H, Saeki H, Oki E, Maehara Y, Mimori K.

Ann Surg Oncol. 2018 Mar;25(3):745-753. doi: 10.1245/s10434-017-6292-6. Epub 2017 Dec 21.

PMID:
29270876
32.

Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer.

Takano Y, Masuda T, Iinuma H, Yamaguchi R, Sato K, Tobo T, Hirata H, Kuroda Y, Nambara S, Hayashi N, Iguchi T, Ito S, Eguchi H, Ochiya T, Yanaga K, Miyano S, Mimori K.

Oncotarget. 2017 Aug 7;8(45):78598-78613. doi: 10.18632/oncotarget.20009. eCollection 2017 Oct 3.

33.

MicroRNAs as Biomarkers in Colorectal Cancer.

Masuda T, Hayashi N, Kuroda Y, Ito S, Eguchi H, Mimori K.

Cancers (Basel). 2017 Sep 13;9(9). pii: E124. doi: 10.3390/cancers9090124. Review.

34.

Japanese genome-wide association study identifies a significant colorectal cancer susceptibility locus at chromosome 10p14.

Takahashi Y, Sugimachi K, Yamamoto K, Niida A, Shimamura T, Sato T, Watanabe M, Tanaka J, Kudo S, Sugihara K, Hase K, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Suzuki Y, Miyano S, Mori M, Mimori K.

Cancer Sci. 2017 Nov;108(11):2239-2247. doi: 10.1111/cas.13391. Epub 2017 Sep 26.

35.

Diagnostic laparoscopy for pneumatosis intestinalis in a very elderly patient: A case report.

Ito S, Masuda T, Harada N, Matsuyama A, Hamatake M, Maeda T, Tsutsui S, Matsuda H, Mimori K, Ishida T.

Ann Med Surg (Lond). 2017 Jul 29;21:109-113. doi: 10.1016/j.amsu.2017.07.058. eCollection 2017 Sep.

36.

Clinical significance of ZNF750 gene expression, a novel tumor suppressor gene, in esophageal squamous cell carcinoma.

Nambara S, Masuda T, Tobo T, Kidogami S, Komatsu H, Sugimachi K, Saeki H, Oki E, Maehara Y, Mimori K.

Oncol Lett. 2017 Aug;14(2):1795-1801. doi: 10.3892/ol.2017.6341. Epub 2017 Jun 8.

37.

Significance of CD47 expression in gastric cancer.

Sudo T, Takahashi Y, Sawada G, Uchi R, Mimori K, Akagi Y.

Oncol Lett. 2017 Jul;14(1):801-809. doi: 10.3892/ol.2017.6257. Epub 2017 May 26.

38.

Long-term outcome of adipose-derived regenerative cell-enriched autologous fat transplantation for reconstruction after breast-conserving surgery for Japanese women with breast cancer.

Ito S, Kai Y, Masuda T, Tanaka F, Matsumoto T, Kamohara Y, Hayakawa H, Ueo H, Iwaguro H, Hedrick MH, Mimori K, Mori M.

Surg Today. 2017 Dec;47(12):1500-1511. doi: 10.1007/s00595-017-1544-4. Epub 2017 May 29.

PMID:
28555267
39.

Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.

Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K.

PLoS Genet. 2017 May 19;13(5):e1006798. doi: 10.1371/journal.pgen.1006798. eCollection 2017 May.

40.

[MicroRNA in Various Aspects of Cancer Development].

Nambara S, Mimori K.

Gan To Kagaku Ryoho. 2017 May;44(5):362-366. Japanese.

PMID:
28536328
41.

DDR2 Expression Is Associated with a High Frequency of Peritoneal Dissemination and Poor Prognosis in Colorectal Cancer.

Sasaki S, Ueda M, Iguchi T, Kaneko M, Nakayama H, Watanabe T, Sakamoto A, Mimori K.

Anticancer Res. 2017 May;37(5):2587-2591.

PMID:
28476831
42.

Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.

Sato K, Masuda T, Hu Q, Tobo T, Kidogami S, Ogawa Y, Saito T, Nambara S, Komatsu H, Hirata H, Sakimura S, Uchi R, Hayashi N, Iguchi T, Eguchi H, Ito S, Nakagawa T, Mimori K.

Anticancer Res. 2017 May;37(5):2365-2371.

PMID:
28476802
43.

Up-regulation of SLC9A9 Promotes Cancer Progression and Is Involved in Poor Prognosis in Colorectal Cancer.

Ueda M, Iguchi T, Masuda T, Komatsu H, Nambara S, Sakimura S, Hirata H, Uchi R, Eguchi H, Ito S, Sugimachi K, Mizushima T, Doki Y, Mori M, Mimori K.

Anticancer Res. 2017 May;37(5):2255-2263.

PMID:
28476790
44.

phyC: Clustering cancer evolutionary trees.

Matsui Y, Niida A, Uchi R, Mimori K, Miyano S, Shimamura T.

PLoS Comput Biol. 2017 May 1;13(5):e1005509. doi: 10.1371/journal.pcbi.1005509. eCollection 2017 May.

45.

Overexpression of heat-shock factor 1 is associated with a poor prognosis in esophageal squamous cell carcinoma.

Tsukao Y, Yamasaki M, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Miyata H, Nakajima K, Takiguchi S, Mimori K, Mori M, Doki Y.

Oncol Lett. 2017 Mar;13(3):1819-1825. doi: 10.3892/ol.2017.5637. Epub 2017 Jan 25.

46.

The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma.

Shibamoto M, Hirata H, Eguchi H, Sawada G, Sakai N, Kajiyama Y, Mimori K.

Oncol Lett. 2017 Mar;13(3):1761-1766. doi: 10.3892/ol.2017.5646. Epub 2017 Jan 25.

47.

Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma.

Sugimachi K, Nishio M, Aishima S, Kuroda Y, Iguchi T, Komatsu H, Hirata H, Sakimura S, Eguchi H, Bekki Y, Takenaka K, Maehara Y, Suzuki A, Mimori K.

Oncology. 2017;93(1):67-74. doi: 10.1159/000463390. Epub 2017 Apr 28.

PMID:
28448997
48.

Extraction of cell-free DNA from urine, using polylysine-coated silica particles.

Takano S, Hu Q, Amamoto T, Refinetti P, Mimori K, Funatsu T, Kato M.

Anal Bioanal Chem. 2017 Jun;409(16):4021-4025. doi: 10.1007/s00216-017-0345-3. Epub 2017 Apr 19.

PMID:
28424857
49.

MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation.

Otsubo K, Goto H, Nishio M, Kawamura K, Yanagi S, Nishie W, Sasaki T, Maehama T, Nishina H, Mimori K, Nakano T, Shimizu H, Mak TW, Nakao K, Nakanishi Y, Suzuki A.

Oncogene. 2017 Jul 20;36(29):4201-4211. doi: 10.1038/onc.2017.58. Epub 2017 Mar 27.

PMID:
28346423
50.

Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.

Komatsu H, Masuda T, Iguchi T, Nambara S, Sato K, Hu Q, Hirata H, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K.

Anticancer Res. 2017 Mar;37(3):1083-1090.

PMID:
28314268

Supplemental Content

Loading ...
Support Center